|
|
||||||||
Evidence-Based Laboratory Medicine and Test Utilization |
1 Laboratoire de Biologie Polyvalente, Centre Hospitalier Général de Rodez, Rodez, France.
2 Laboratoire de Biologie Polyvalente, Centre Hospitalier Général de Wissembourg, Wissembourg, France.
3 Department of Clinical Chemistry, University of Szeged, Szeged, Hungary.
4 Department of Clinical Chemistry, Atrium Medical Centre, Heerlen, The Netherlands.
5 Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.
6 Service de Pneumologie, Centre Hospitalier Général de Rodez, Rodez, France.
aAddress correspondence to this author at: Laboratoire de Biologie Polyvalente, Hôpital Général, F-12027 Rodez Cédex 9, France. Fax 33-5-6575-1973; e-mail j.watine{at}ch-rodez.fr-watine61@hotmail.com.
Background: It is not clear if good methodologic quality in current practice guidelines necessarily leads to more valid recommendations, i.e., those that are supported with consistent research evidence or, when evidence is conflicting or lacking, with sufficient consensus among the guideline development team. To help clarify this issue, we assessed whether there is a link between methodologic quality and recommendation validity in practice guidelines for the use of laboratory tests in the management of patients with non-small cell lung cancer (NSCLC).
Methods: We conducted a systematic review of data on laboratory tests in NSCLC published in English or in French within the last 10 years and retrieved 11 practice guidelines for the use of these tests. The guidelines were critically appraised and scored for methodologic quality and recommendation validity based on the Appraisal of Guidelines Research and Evaluation (AGREE) criteria and on the systematic review.
Results: Overall, these 11 guidelines had considerable shortcomings in methodologic quality and, to a lesser extent, in recommendation validity. Practice guidelines with the best methodologic quality were not necessarily the most valid in their recommendations, and conversely.
Conclusions: Poor methodologic quality and lack of recommendation validity in laboratory medicine call for methodologic standards of guideline development and for international collaboration of guideline development agencies. We advise readers of guidelines to critically evaluate the methods used as well as the content of the recommendations before adopting them for use in practice.
The following articles in journals at HighWire Press have cited this article:
![]() |
S. Mickan and D. Askew What sort of evidence do we need in primary care? BMJ, March 18, 2006; 332(7542): 619 - 620. [Full Text] [PDF] |
||||
![]() |
J. S. Burgers Guideline Quality and Guideline Content: Are They Related? Clin. Chem., January 1, 2006; 52(1): 3 - 4. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |